filmov
tv
COVID 19 Vaccine Update with Professor Michael Mina, MD: Safety, Efficacy, Distribution, Trials

Показать описание
Harvard professor and epidemiologist Michael Mina MD, Ph.D. is back to give a COVID 19 Vaccine Update including:
00:00 Attention to vaccine safety in phase one, two, and three trials
00:21 Mild side effects from vaccines observed in phase 1 and 2 trials
00:32 Awareness of "fringe effects" when the vaccine is introduced to thousands or millions
00:59 Post-market surveillance of adverse effects vs. coincidence and confounding
01:31 Ensuring efficacy - new territory with a coronavirus vaccine
01:50 Sterilizing immunity
02:06 Relatively weak immune response from coronaviruses vs severity
02:29 Polio and measles vaccines create robust immunity
02:59 New technology being used in some SARS-CoV-2 vaccines
03:47 Cautious optimism about the efficacy of vaccines
04:02 Herd immunity
04:43 Who is going to get the COVID-19 vaccine first? Which countries?
05:15 Medical professionals likely the first to receive vaccines
06:02 Will COVID 19 vaccines block transmission and spread?
06:10 Should kids get the vaccine?
06:37 How well will vaccines work in the elderly and immunocompromised?
07:46 How quickly can the COVID vaccines get distributed? By the end of this year?
MedCram has no financial disclosures related to any medical products or vaccines, and from our understanding, Dr. Mina does not either.
THE MEDCRAM WEBSITE:
MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS:
SUBSCRIBE TO THE MEDCRAM YOUTUBE CHANNEL:
Get notified of new videos by hitting the bell icon:
OTHER MEDCRAM VIDEOS FEATURING DR. MICHAEL MINA:
FOLLOW US ON SOCIAL MEDIA:
DISCLAIMER:
MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor.
------------------------------------------------------
#COVID19 #SARSCOV2 #Science
00:00 Attention to vaccine safety in phase one, two, and three trials
00:21 Mild side effects from vaccines observed in phase 1 and 2 trials
00:32 Awareness of "fringe effects" when the vaccine is introduced to thousands or millions
00:59 Post-market surveillance of adverse effects vs. coincidence and confounding
01:31 Ensuring efficacy - new territory with a coronavirus vaccine
01:50 Sterilizing immunity
02:06 Relatively weak immune response from coronaviruses vs severity
02:29 Polio and measles vaccines create robust immunity
02:59 New technology being used in some SARS-CoV-2 vaccines
03:47 Cautious optimism about the efficacy of vaccines
04:02 Herd immunity
04:43 Who is going to get the COVID-19 vaccine first? Which countries?
05:15 Medical professionals likely the first to receive vaccines
06:02 Will COVID 19 vaccines block transmission and spread?
06:10 Should kids get the vaccine?
06:37 How well will vaccines work in the elderly and immunocompromised?
07:46 How quickly can the COVID vaccines get distributed? By the end of this year?
MedCram has no financial disclosures related to any medical products or vaccines, and from our understanding, Dr. Mina does not either.
THE MEDCRAM WEBSITE:
MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS:
SUBSCRIBE TO THE MEDCRAM YOUTUBE CHANNEL:
Get notified of new videos by hitting the bell icon:
OTHER MEDCRAM VIDEOS FEATURING DR. MICHAEL MINA:
FOLLOW US ON SOCIAL MEDIA:
DISCLAIMER:
MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor.
------------------------------------------------------
#COVID19 #SARSCOV2 #Science
Комментарии